(Q38463092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

Nanomedicine as an emerging platform for metastatic lung cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Dalit Landesman-Milo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Srinivas Ramishetti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

Cancer and Metastasis Reviews

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

291-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Extending survival of stage IV non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Targeting the invasive phenotype of cisplatin-resistant non-small cell lung cancer cells by a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Circumventing tumor resistance to chemotherapy by nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Grand challenges in modulating the immune response with RNAi nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Altering the immune response with lipid-based nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Doxil®--the first FDA-approved nano-drug: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Expression of pigment epithelium-derived factor in human melanocytes and malignant melanoma cells and tissues: Is loss of pigment epithelium-derived factor associated with melanoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Systemically administered liposome-encapsulated Ad-PEDF potentiates the anti-cancer effects in mouse lung metastasis melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Apoptosis-inducing high (.)NO concentrations are not sustained either in nascent or in developed cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Solid lipid nanoparticles as nucleic acid delivery system: properties and molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Endosomal escape: a bottleneck in intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Toxicity profiling of several common RNAi-based nanomedicines: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

RNA interference-based therapeutics and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

RNAi-based nanomedicines for targeted personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Special delivery: targeted therapy with small RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Lipid envelope-type nanoparticle incorporating a multifunctional peptide for systemic siRNA delivery to the pulmonary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Nanoparticles for imaging, sensing, and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Overcoming multidrug resistance with nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Polymer therapeutics: Top 10 selling pharmaceuticals - what next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Cell-penetrating peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Complexation of cell-penetrating peptide-polymer conjugates with polyanions controls cells uptake of HPMA copolymers and anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

The hypercoagulable state of malignancy: pathogenesis and current debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

A daunting task: manipulating leukocyte function with RNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Polysaccharides as building blocks for nanotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-015-9554-4

10.1007/S10555-015-9554-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 March 2020

1021953194

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25948376%20AND%20SRC:MED&resulttype=core&format=json